RHOB and pachyonychia congenita: The results of co-transfection with RhoB and hsa-miR-3178 and treatment with PI3K inhibitor LY294002 and PI3K agonist 740Y-P further suggested that RhoB reduces proliferation and gemcitabine resistance by antagonizing the PI3K/Akt signaling pathway in PC cells.